Without prejudice to the applicable legislation concerning intellectual property, documents and data related to an innovative Medical Product and a Medical Product with at least one new active ingredient, whether developed in the State or imported, are subject to a protection period. The Executive Regulations of this Decree-Law shall specify the period, mechanism and system related to regulatory protection.
Interpretation and application must be checked against the official text and current version.